investorideas.com / .investorideas-com / Page 3

Gold, silver, and miners moved higher alongside stocks and bitcoin in a broad short-term optimism rally. Analyst Przemyslaw Radomski argues the move is not PM-specific and is likely to reverse as bearish fundamentals remain intact.

Global investors rotate away from US equities despite record highs highlighted in the State of the Union, as capital flows shift toward Europe and Asia amid diversification and sector concentration concerns. Market commentary from deVere Group CEO ...

February 25, 2026 (Investorideas.com Newswire) Rio Silver Inc. (TSX-V: RYO | OTC: RYOOF) announces a $3.0 million non-brokered private placement led by Eric Sprott to advance its Maria Norte Project in Peru. The offering will fund access development,

February 25, 2026 (Investorideas.com Newswire) VisionWave Holdings, Inc. (Nasdaq: VWAV) has engaged Paul Hastings LLP to prepare and file a civil complaint addressing suspected trading irregularities in the Company's stock, declaring zero tolerance ...

February 25, 2026 (Investorideas.com Newswire) Locksley Resources Limited (ASX: LKY, OTCQX: LKYRF) commences diamond drilling at the high-grade Desert Antimony Mine within its Mojave Project in California, advancing U.S. critical mineral supply with ...

February 25, 2026 (Investorideas.com Newswire) West Point Gold Corp. (TSXV: WPG) (OTCQB: WPGCF) reports drill results for four holes at the high-grade NE Tyro zone at its Gold Chain Project in Arizona, including 21.3m of 13.48 g/t Au and 32.0m of 4 ...

February 25, 2026 (Investorideas.com Newswire) Nasdaq and S&P 500 stage a failed breakdown as traders position ahead of NVDA earnings. ES reaches 6,905 target while gold intraday longs deliver profits. Market outlook and earnings momentum analysis ...

Sunday open gap, repeated premarket rejections below 6,885, and NVDA earnings anxiety are fueling market jitters. Dollar recovery erases Sunday weakness as risk-off positioning builds ahead of a volatile week.

Edesa Biotech (Nasdaq: EDSA) surges to Nasdaq top gainers after Phase 3 paridiprubart study shows 27% relative reduction in 28-day mortality across 278 patients, with consistent benefits in sepsis, acute kidney injury, and pneumonia cases.

deVere Group CEO Nigel Green warns the AI scare trade hitting logistics, software, payments, and wealth management is a serious market signal, not noise, as capital is repriced around AI displacement risk in real time.